# A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment

> **NCT01966328** · PHASE1 · COMPLETED · sponsor: **Jeffrey S Heier** · enrollment: 21 (actual)

## Conditions studied

- Vitreomacular Attachment
- Vitreomacular Traction
- Vitreomacular Adhesion

## Interventions

- **DRUG:** 36% Resolvine Intravitreal Injection
- **DRUG:** 9% Resolvine Intravitreal Injection

## Key facts

- **NCT ID:** NCT01966328
- **Lead sponsor:** Jeffrey S Heier
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2016-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01966328

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01966328, "A Safety and Efficacy Assessment of Resolvine for Treatment of Vitreomacular Attachment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01966328. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*